Condition: Adult Subjects With Symptomatic Benign Airway Obstruction · Adult Benign Central Airway Stenosis · Adult Tracheobronchial Stenosis · Sponsor: Airiver Medical, Inc.
The OXYGEN-RCT trial is a randomized, controlled, double blinded, prospective, multi-center trial to demonstrate the safety and efficacy in adult benign central airway stenosis. Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of care laryngoscopic/bronchoscopic balloon dilation, respectively.
This description comes directly from the study's public registry record.
Robyn Schacherer, RN · 6123108755 · schachererr@airiver.com
Mitch Erickson · 6518954399 · ericksonm@airiver.com
Always discuss trial participation with your own doctor first.
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07191860